Dapagliflozin effectiveness in improvement of clinical outcomes in diabetic patients (extention of CARDIA-MOS study, Moscow) by M. B. Antsiferov, N. A. Demidov

Get full text

Impact of dapagliflozin on life expectancy in type 2 diabetes mellitus patients in routine practice by M. B. Antsiferov, N. A. Demidov, N. A. Tabakaev

Get full text

Results of a clinical trial of the efficacy and safety of vildagliptin and metformin fixed combination in real clinical practice in Russia (MASTER study) by N. A. Demidov, M. B. Antsiferov, A. V. Zilov

Get full text

Pharmacoepidemiological analysis of type 1 diabetes mellitus insulin therapy (According to the Moscow segment of the State Register of Diabetes Mellitus) by M. B. Antsiferov, M. A. Kantemirova, N. A. Demidov, M. F. Kalashnikova

Get full text

Real World Effectiveness of fixed combination of glargine 100 U/ml and lixisenatide therapy in outpatients with Type 2 Diabetes: A Retrospective Cohort Study SOLO by M. B. Antsiferov, N. A. Demidov, M. A. Balberova, T. I. Safronova, O. A. Mishra, S. G. Magomedova

Get full text

Influence of type 2 sodium-glucose co-transporter inhibitors (dapagliflozin) on the indicators of total mortality in patients with type 2 diabetes (CARDIA-MOS study, Moscow) by M. B. Antsiferov, N. A. Demidov, M. A. Balberova, O. V. Lobanova, I. G. Mudrikova, D. G. Gusenbekova

Get full text

Endocrine aspect of overtraining in athletes by Z. G. Ordzhonikidze, N. A. Demidov, V. I. Pavlov, V. A. Badtieva, A. S. Rezepov, O. S. Volkova, S. G. Plotnikov, M. V. Gvinianidze

Get full text